“…The study by Chandran et al. 1 is an innovative and multifaceted approach involving targeted delivery, RNA interference, live-attenuated bacteria, and the complex interplay in breast cancer evolution and metastasis. Salmonella-mediated long non-coding (lnc) antisense RCAS1 (receptor-binding cancer antigen expressed on SiSo cells) RNA therapy showed a significant reduction in breast tumor volumes and completely arrested the metastatic lung lesions via mechanisms involving suppression of tumor-promoting genes, reduction in tumor-associated suppressor macrophages (TAMs), and efficient activation of T cell responses.…”